PIMJS
PKO Investment Management Joint-Stock Portfolio holdings
AUM
$931M
1-Year Return
16.38%
This Quarter Return
+8.24%
1 Year Return
+16.38%
3 Year Return
+65%
5 Year Return
+112.48%
10 Year Return
+522.82%
AUM
$841M
AUM Growth
+$40.6M
(+5.1%)
Cap. Flow
-$21.5M
Cap. Flow
% of AUM
-2.55%
Top 10 Holdings %
Top 10 Hldgs %
56.43%
Holding
164
New
21
Increased
30
Reduced
60
Closed
5
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$5.7M |
| 2 |
Intel
INTC
|
$4.66M |
| 3 |
Intuit
INTU
|
$4.02M |
| 4 |
Tesla
TSLA
|
$3.99M |
| 5 |
Lam Research
LRCX
|
$3.95M |
Top Sells
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
$17.9M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
$14.7M |
| 3 |
Microsoft
MSFT
|
$8.88M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$6.83M |
| 5 |
NVIDIA
NVDA
|
$3.63M |
Sector Composition
| 1 | Materials | 16.19% |
| 2 | Technology | 12.23% |
| 3 | Consumer Discretionary | 7.28% |
| 4 | Healthcare | 7.1% |
| 5 | Energy | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
BioMarin Pharmaceuticals
BMRN
$11.1B
| $790K | 0.09% |
9,000
+3,000
| +50% | +$263K |
|
127
First Majestic Silver
AG
$4.47B
| $772K | 0.09% |
131,500
| – | – |
|
128
Biogen
BIIB
$20.6B
| $758K | 0.09% |
3,500
+1,500
| +75% | +$325K |
|
129
Coeur Mining
CDE
$9.43B
| $758K | 0.09% |
200,000
| – | – |
|
130
Polaris
PII
$3.33B
| $755K | 0.09% |
7,500
| – | – |
|
|
DRD
131
DRDGold
DRD
$1.83B
| $748K | 0.09% |
90,814
| – | – |
|
132
FMC
FMC
$4.72B
| $743K | 0.09% |
11,600
+6,100
| +111% | +$390K |
|
133
Gilead Sciences
GILD
$143B
| $736K | 0.09% |
10,000
+5,000
| +100% | +$368K |
|
134
Signet Jewelers
SIG
$3.85B
| $704K | 0.08% |
+7,000
| New | +$704K |
|
|
MAG
135
DELISTED
MAG Silver
MAG
| $695K | 0.08% |
65,918
+40,000
| +154% | +$422K |
|
136
NexGen Energy
NXE
$4.46B
| $684K | 0.08% |
88,000
-72,000
| -45% | -$560K |
|
137
SSR Mining
SSRM
$4.28B
| $677K | 0.08% |
152,128
-16,000
| -10% | -$71.2K |
|
138
Rivian
RIVN
$17.2B
| $638K | 0.08% |
58,000
+18,000
| +45% | +$198K |
|
139
Steel Dynamics
STLD
$19.8B
| $611K | 0.07% |
4,100
-900
| -18% | -$134K |
|
140
Reliance Steel & Aluminium
RS
$15.7B
| $592K | 0.07% |
1,764
-636
| -27% | -$214K |
|
141
Incyte
INCY
$16.9B
| $572K | 0.07% |
10,000
-500
| -5% | -$28.6K |
|
142
Ralph Lauren
RL
$18.9B
| $566K | 0.07% |
3,000
-5,000
| -63% | -$943K |
|
143
Boston Scientific
BSX
$159B
| $551K | 0.07% |
8,000
-4,000
| -33% | -$275K |
|
144
RH
RH
$4.7B
| $525K | 0.06% |
+1,500
| New | +$525K |
|
145
Ovintiv
OVV
$10.6B
| $469K | 0.06% |
+9,000
| New | +$469K |
|
146
EQT Corp
EQT
$32.2B
| $417K | 0.05% |
+11,200
| New | +$417K |
|
147
Idexx Laboratories
IDXX
$51.4B
| $380K | 0.05% |
700
| – | – |
|
148
Moderna
MRNA
$9.78B
| $375K | 0.04% |
3,500
-23,500
| -87% | -$2.52M |
|
149
The Mosaic Company
MOS
$10.3B
| $359K | 0.04% |
11,000
-3,300
| -23% | -$108K |
|
150
DexCom
DXCM
$31.6B
| $348K | 0.04% |
2,500
-1,500
| -38% | -$209K |
|